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Background: The incidence of candidaemia is steadily increasing in
n is considered a virulence factor responsible for catheter-related
candidaemia.
Objective: To investigate the capacity of bloodstream Candida iso-
lates from NICU neonates to form BF and the degree of BF produc-
tion.
Methods: 5x10 5 planktonic (PL) cells/mL were grown in YNB
medium with 2% glucose at 37°C for 24h. For BF formation, 10
6 cells/mL were grown on silicone disks placed at the bottom of
96-well plates in RPMI-1640 under constant shaking at 37°C for
48-72 h. BF production was then evaluated by XTT metabolic as-
say, safranin staining and light microscopy (LM). Documented BF
producers (CA-M61 and CP/PA71) were used as positive controls
(metabolic activity by XTT assay: 100%). Isolates that a) showed
XTT conversion ≥80% of positive controls, b) stained with safranin
and c) produced a microscopically visible dense fungal network
were considered high BF producers. XTT conversion of <80% de-
fined non-BF producers, while conversion ≥80% with inconsistent
safranin and LM findings defined low BF producers. All isolates were
tested in triplicate at 3 different experiments.
Results: A total of 31 isolates coming from equal in number NICU
neonates (12 male-19 female) with Candida bloodstream infections
were examined. Among these isolates, 58% were Candida albicans
(CA), 19% were Candida parapsilosis (CP), 7% were Candida lusita-
niae (CL) and Candida guilliermondii (CG), respectively, 3% were
Candida glabrata (CGl), Candida tropicalis (CT) and other Candida
spp. (Cs), respectively. BF production was detected in all CG and
CT isolates, in 88% of CA, in 50% of CL and in 17% of CP. CGl and
Cs isolates did not produce BF. Among CG and CT isolates, all were
high BF producers, 56% and 28% CA isolates were high and low BF
producers, respectively.
Conclusions: BF-forming capacity is a frequent characteristic
among Candida clinical isolates, especially for CG, CT, CA but not
for CGl. These results may provide the means to design novel ther-
apies for BF-related infections.
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Infection Complications of Immunosuppression in Liver
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Background: The consequences of immunosuppression post liver
transplantation are, first, organ rejection, followed by bacterial
and fungal infections. Increasing or decreasing the serum level
beyond the advised doses of immunosuppresor has major impact
on infections. Pre-transplant health status, the complexity of the
surgery, post-transplant immunosuppression therapy, and possible
rejection are factors that affect the potential for bacterial and
fungal infections as determined in the laboratory.
Materials and methods: This study was a collaboration of the Cen-
ter of General Surgery, Liver Transplantation, Microbiology Depart-
ment and other departments of the Fundeni Clinical Institute. The
study comprised 126 liver transplant patients, of whom 61 had fun-
gal infections with Candida albicans/non-albicans and 89 had bac-
terial infections including Methicillin Resistant Staphylococcus au-
reus (MRSA), Entorococcus spp., Escherichia coli, Klebsiella spp.,
Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Acineto-
bacter baumanii calcoaceticus complex, and others. Bacteria and
fungi were isolated from typical biological products cultivated on
usual and special media after fixing the direct smear from a fresh
or colorized specimen (Gram, Fast Quick Giemsa, Methylene blue,
etc).
Results: Colonizers, bacterial episodes, and multi-bacterial sep-
sis were detected.Microorganisms detected in various pathologic
products from 126 liver transplant patients were: Staphylococcus
spp (40-43%), Enterococcus spp. (7-10%), Acinetobacter spp. (21-
25%), Pseudomonas aeruginosa (9-16%), Stenotrophomonas mal-
tophilia (2-5%), Escherichia coli (57-60%), Klebsiella spp. (3-7%),
Enterobacter spp. (3-5%), other bacteria (1-2%), Candida albicans
(32-35%), Candida glabrata (5-7%), Candida famata (7-8%), and
other non-albicans (2-3%).
Conclusion: More than 2/3 of liver transplant recipients experi-
ence infections, which are the primary cause of organ rejection.
They occur after surgical re-intervention and high-dose immuno-
suppression. More than 60% of the infections were bacterial; and
8-9% fungal.
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Background: Respiratory virus infections (RV) infections are in-
creasingly recognized as a significant threat to immunocompro-
mised hosts. Higher rates of progression to pneumonia and major
impact on bronchiolitis obliterans are observed after lung trans-
plantation (LT).
Objectives: Describe the epidemiology of RV infections in LT recip-
ients.
Methods: Prospective cohort study of 45 LT recipients. All patients
received the same triple immunosuppressive therapy. Nasopharyn-
geal wash (NW) and bronchoalveolar lavage (BAL) were obtained
from Feb/07-Jan/08 whenever symptoms or image findings were
present. DFA and PCR were used to detect influenza A and B virus
(IFV), parainfluenza virus (PIV), metapneumovirus (hMPV), coron-
avirus, respiratory syncitial virus (RSV) and adenovirus (ADV).
Results: Twenty-six of the 45 alive patients (57.7%) followed-up
at the InCor-LT program experienced 40 respiratory events (1.53
event/patient). Respiratory symptoms were mostly observed dur-
ing fall and winter, with 86% of the events occurring between fall
and spring (median time of 425 days after LT; range 19–1487). Pa-
tients' median age was 37 years old (18 to 67), 18 were male and
18 had bilateral LT. RV were detected in 16 of the 40 episodes
(40%). Only 37% of the positive samples were obtained during win-
ter. Three patients had RV co-infection and three had two episodes
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Abstract 18 – Table 1. Characteristics of the 13 patients with positive samples for respiratory virus
Patient Sample Virus Symptom/Image Treatment
1 NW IFV A+RSV Coryza, wheezing and dyspnea Oseltamivir
2 BAL hMPV Coryza and sore throat Aciclovir for oral herpes
3 BAL ADV+hMPV Respiratory failure Prophylatic Ganciclovir
4 BAL IFV A Coryza Oseltamivir
5 NW hMPV Coryza and cough None
BAL hMPV Pulmonary nodule None
6 NW IFV A Coryza, cough and fever Oseltamivir
7 NW PIV Intense cough None
8 BAL hMPV Thickened airway at chest CT None
NW PIV Coryza and cough Prophylactic oselltamivir
9 NW IFV A Respiratory failure Oseltamivir
NW hMPV Coryza and cough None
10 NW RSV+hMPV Coryza and cough None
11 BAL hMPV Dyspnea Aciclovir for oral herpes
12 BAL hMPV Bronchi hyperemia Ganciclovir for CMV colitis
13 NW hMPV Coryza and headache None
of RV infection. Other RV identified are shown in table 1. One pa-
tient died because of ADV infection.
Conclusions: Respiratory events are common after LT and may
cause significant morbidity. Rapid diagnosis of RV infections favors
early treatment and may help to differentiate from other condi-
tions. In our country, RV circulate year round, though more fre-
quently during winter months.
19
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Introduction: An analysis of bacterial infections in the early post-
transplant period after liver transplantation in adults.
Material and Methods: The study covered 83 adult patients un-
dergoing liver transplantation from 2001 to the end of 2004. All
the patients were followed prospectively for infections from the
LT date and during the first four weeks after surgery. Basic im-
munosuppression consisted of steroids and tacrolimus. Antimicro-
bial prophylaxis was administered intravenously from the day of
transplantation: piperacillin/tazobactam, fluconazole and selec-
tive bowel decontamination (orally a liquid suspension of amikacin
and nystatin) was carried out. Samples of clinical materials (blood,
urine, wound swabs, stool and other) were investigated. The mi-
croorganisms were cultured and identified in accordance with stan-
dard bacteriological procedures. Susceptibility testing was carried
out using (NCCLS) procedures. The statistical analysis was made by
chi-square test.
Results: 913 clinical samples taken from liver recipients were in-
vestigated in microbiological laboratory. In total 469 strains were
cultured. Among the bacterial strains, the most common were
Gram-positive bacteria n=331 strains (70.6%), Gram-negative bac-
teria n=133 strains (28.4%) and yeast like fungi n=5 strains (1%).
In the early posttransplant period the common isolates were taken
from Surgical Site Area n=284 (60%) with predomination of Gram-
positive strains n=222 (78%), Gram-negative strains n=61 (21.5%).
From blood n=99 strains (21.1%) were cultured: Gram-positive
n=75 (75.8%) and Gram-negative n=22 (22.2%). Urine samples n=73
(15.6%): among them Gram-negative n=46 (63%), Gram-positive
n=25 (34%), fungi n=2 (3%). Samples taken from respiratory tract
n=13 (2.8%) strains were cultured: Gram-positive n=9 (69%), Gram-
negative n=4 (31%). From 54 stool samples Clostridium difficile
toxins were positive in 63%, only in 16.7% of samples C.difficile
strains were detected, 30% were negative. We analyzed the sus-
ceptibility of cultured strains to antibacterial agents. In total n=10
strains of (MRSA), n=138 of (MRCNS) staphylococci were detected,
86% of enterococci were (HLAR) strains and from Enterobacteri-
aceae family 12.5% (ESBL) rods were detected.
Conclusions: The presence of (MDR) bacterial strains after liver
transplantation such as: methicillin-resistant staphylococci (MRSA)
– 52.6%, (MRCNS) 81.7%, enterococci (HLAR) 86%, enteric Gram-
negative bacteria (ESBL) 12.5% required better professional infec-
tion controls.
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Introduction: Urinary Tract Infection (UTI) is a one of the common
infection in liver transplantation (LT).
Patients and Methods: The study covered 83 adult patients un-
dergoing liver transplantation (piggy back technique) between
September 2001 and October 2004. All the patients were followed
prospectively for urinary tract infections from the LT date and dur-
ing the first four weeks after surgery. Samples of urine were in-
vestigated for bacteriological cultures. The microorganisms were
cultured and identified in accordance with standard bacteriolog-
ical procedures. Susceptibility testing was carried out using Na-
tional Committee for Clinical Laboratory Standards (NCCLS) proce-
dures.
Results: Urine specimens were examined in 53 pre-operative re-
cipients (63.9%) and in 64 patients (77.1%) during the first month
after transplantation. Of the 182 samples investigated, 73 were
positive. Bacterial strains were cultured from 17 recipients before
LT and from 28 patients after surgery. Among the bacterial strains
isolated in early period after LT (n=71), the most common were
Gram-negative rods n=46 (63%) isolates, the Enterobacteriaceae
family n=44 (95.6%) isolates among them n=12 (27.3%) of the Gram-
negative rods were Extended-Spectrum Beta-Lactamases ESBL pos-
